Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Sankyo's calpain inhibitor for neurological disorders, restenosis

May 24, 1996

E. Merck describes NMDA ligands for neurodegeneration

May 24, 1996

Lilly's new series of muscarinic cholinergic receptor agonists

May 24, 1996

Fujisawa, Nihon Shokubai claim CCK-B antagonists

May 24, 1996

ADIR claims melatonin receptor ligands for CNS disorders

May 24, 1996

Isis claims oligonucleotides for diagnostic use

May 24, 1996

Ortho claims agents for osteoporosis

May 24, 1996

Role of DF3 in human carcinoma and potential therapeutics

May 24, 1996

Ajinomoto reports antitumor antibiotic

May 24, 1996

Ciba-Geigy claims matrix metalloproteinase inhibitors

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...